DNLI

Denali Therapeutics Inc.

CIK 0001714899 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)

$27.21

↑ 0.52 (1.95%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals

Key stats

Market Cap

$4.32B

P/E Ratio

-8.50

EPS

-2.97

Dividend Yield

Not covered

52W Position

99%

Beta

1.56

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

4.66

P/S

Not covered

EV/Revenue

Not covered

ROE

-54.9%

Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 99%

$12.58$27.30

Latest Financials

2025-12-31 FY

Revenue

$0.00

Net Income

-$512.54M

Total Assets

$1.14B

Free Cash Flow

-$422.10M

DNLI

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

DNLI

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news